Founded

Address

Aberdare Ventures
One Embarcadero Center
Suite 4000
San Francisco, CA 94111
United States

Open map


Recent investment activity

KANDO id: 28057

Corporate information

Registration country

Funds managed

Fund Type Vintage Currency Committed capital IRR x
Aberdare Ventures IV LP 2008 4.70 % 1.20 x
Aberdare Ventures III LP Venture 2005 USD 154,000,000 2.90 % 1.20 x
Aberdare Ventures LP Venture USD 50,000,000
Aberdare Ventures II LP Venture USD 50,000,000

Funding rounds

Top investment portfolio themes
healthcare (3)  
micro-VC (1)  


Investment activity status
Active investor

Selected investments

Displaying 1 - 20 of 34
Profile Country Date Funding
Autonomic Technologies Inc N/A
Aviir Inc Assists in the prevention of cardiovascular disease and management of related conditions by delivering innovative cardiometabolic tests and associated N/A
Cervel Neurotech Inc N/A
Clovis Oncology Inc N/A
Conatus Pharmaceuticals Inc Biotechnology company focused on the development of innovative human therapeutics to treat liver disease and cancer. N/A
EnteroMedics Inc Develops therapeutic devices for the treatment of obesity. Its VSM technology uses electrical signals, delivered by an implantable electrode array, to N/A
goBalto Inc N/A
IDUN Pharmaceuticals Inc N/A
Ironwood Pharmaceuticals Inc Entrepreneurial pharmaceutical company, engages in developing and marketing human medicines. N/A
Jiff Inc N/A
KAI Pharmaceuticals Inc N/A
mc10 Inc N/A
Mpex Pharmaceuticals Inc N/A
Nevro Corp Medical device company marketing novel neuromodulation therapies for the treatment of chronic, intractable pain. Series A
Nevro Corp Medical device company marketing novel neuromodulation therapies for the treatment of chronic, intractable pain. N/A
NxThera Inc N/A
Omada Health N/A
Paracor Medical Inc Developed a ventricular elastic support therapy Series D
Pharmion Corp Initially, Pharmion concentrated its efforts on licensing products in the areas of hematology, oncology and supportive care. N/A
Portaero Inc N/A

Financials